JENSEN VOLZ: Open Payments
NPI 1043996713 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 9 payments from 8 companies in 2025. Trend: 2023 $143 · 2024 $695 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $124 |
| Lilly USA, LLC | 1 | $109 |
| Genentech USA, Inc. | 2 | $53 |
| ARGENX US, INC. | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
Products named: BRIUMVI, OMVOH, VYVGART HYTRULO, Ocrevus, TREMFYA, Ocrevus Zunovo, TEZSPIRE, ONPATTRO.
Industry payments across TX — which companies pay providers there.
